NCT06330974Enrolling by invitation
Allergy, Asthma, and Atopic Eczema in Finland
Allergy, Asthma, and Atopic Eczema in Finland - A Nationwide Study on Prevalence, Comorbidities, Treatment and Economic Burden
Source: ClinicalTrials.gov · Last updated 27 Oct 2026
Brief summary (registry, in English)
The summary is available at --\> https://www.finnatopy.fi/summary
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 1600000 (estimated)
- First submitted
- 12 Mar 2024
- Start date
- 1 Oct 2026
- Primary completion date
- Dec 2032
- Lead sponsor
- Tampere University
- Diseases
- Atopic dermatitis (eczema), Asthma
- NCT number
- NCT06330974
What you commit to
- Study type: Observational
- Planned participants: 1600000
- From 1 Oct 2026 to the primary completion date, Dec 2032
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Inclusion/Exclusion Criteria ---\> https://www.finnatopy.fi/methods
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tampere University Coordinator of this site? Confirm its status | Tampere | Finland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.